doi: 10.1210/js.2018-00315.
eCollection 2019 Mar 1.
Commentary: Next-Generation Sequence Analysis of Parathyroid Carcinoma
Affiliations
- PMID: 30793092
- PMCID: PMC6378759
- DOI: 10.1210/js.2018-00315
Item in Clipboard
Commentary: Next-Generation Sequence Analysis of Parathyroid Carcinoma
J Endocr Soc.
.
No abstract available
Keywords: CDC73; MEN1; parathyroid carcinoma; primary hyperparathyroidism.
Similar articles
-
Clinical and molecular characterization of parathyroid carcinoma in multiple endocrine neoplasia type 1.Endocr Connect. 2023 Aug 2;12(9):e220479. doi: 10.1530/EC-22-0479. Endocr Connect. 2023. PMID: 37410092 Free PMC article.
-
Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome.Endocr Connect. 2017 Nov;6(8):557-565. doi: 10.1530/EC-17-0126. Epub 2017 Sep 4. Endocr Connect. 2017. PMID: 28870973 Free PMC article.
-
Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing.Front Endocrinol (Lausanne). 2022 Apr 28;13:853171. doi: 10.3389/fendo.2022.853171. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35586626 Free PMC article. Review.
-
Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family.BMC Med Genet. 2017 Aug 3;18(1):83. doi: 10.1186/s12881-017-0445-0. BMC Med Genet. 2017. PMID: 28774260 Free PMC article.
-
Rare duplication of the CDC73 gene and atypical hyperparathyroidism-jaw tumor syndrome: A case report and review of the literature.Mol Genet Genomic Med. 2023 May;11(5):e2133. doi: 10.1002/mgg3.2133. Epub 2023 Jan 14. Mol Genet Genomic Med. 2023. PMID: 36639964 Free PMC article. Review.
Cited by
-
MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders.Eur J Endocrinol. 2019 Sep 1;181(3):P1-P19. doi: 10.1530/EJE-19-0316. Epub 2019 Jun 1. Eur J Endocrinol. 2019. PMID: 31176307 Free PMC article. Review.
-
Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma.Exp Mol Med. 2023 May;55(5):886-897. doi: 10.1038/s12276-023-00968-4. Epub 2023 May 1. Exp Mol Med. 2023. PMID: 37121965 Free PMC article.
References
-
- El-Hajj Fuleihan G, Arnold A. Parathyroid carcinoma. Available at: www.uptodate.com/contents/parathyroid-carcinoma. Accessed 10 October 2018.
-
- Clarke CN, Katsonis P, Hsu TK, Koire AM, Silva-Figueroa A, Christakis I, Williams MD, Kutahyalioglu M, Kwatampora L, Xi Y, Lee JE, Koptez ES, Busaidy NL, Perrier ND, Lichtarge O. Comprehensive genomic characterization of parathyroid cancer identifies novel candidate driver mutations & core pathways. J Endocr Soc 2019;3(3):544–559. - PMC - PubMed
-
- Pandya C, Uzilov AV, Bellizzi J, Lau CY, Moe AS, Strahl M, Hamou W, Newman LC, Fink MY, Antipin Y, Yu W, Stevenson M, Cavaco BM, Teh BT, Thakker RV, Morreau H, Schadt EE, Sebra R, Li SD, Arnold A, Chen R. Genomic profiling reveals mutational landscape in parathyroid carcinomas. JCI Insight. 2017;2(6):e92061. - PMC - PubMed
-
- Yu W, McPherson JR, Stevenson M, van Eijk R, Heng HL, Newey P, Gan A, Ruano D, Huang D, Poon SL, Ong CK, van Wezel T, Cavaco B, Rozen SG, Tan P, Teh BT, Thakker RV, Morreau H. Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion. J Clin Endocrinol Metab. 2015;100(2):E360–E364. - PubMed
-
- Kasaian K, Wiseman SM, Thiessen N, Mungall KL, Corbett RD, Qian JQ, Nip KM, He A, Tse K, Chuah E, Varhol RJ, Pandoh P, McDonald H, Zeng T, Tam A, Schein J, Birol I, Mungall AJ, Moore RA, Zhao Y, Hirst M, Marra MA, Walker BA, Jones SJ. Complete genomic landscape of a recurring sporadic parathyroid carcinoma. J Pathol. 2013;230(3):249–260. - PubMed
LinkOut - more resources
Full Text Sources